| scholarly article | Q13442814 |
| P356 | DOI | 10.1136/GUTJNL-2011-300411 |
| P698 | PubMed publication ID | 21917650 |
| P50 | author | Hongchuan Jin | Q37380045 |
| P2093 | author name string | Jun Yu | |
| Joseph J Y Sung | |||
| Qian Tao | |||
| Minnie Y Y Go | |||
| Eagle S H Chu | |||
| Guijun Zhao | |||
| Zhirong Zeng | |||
| Lixia Xu | |||
| Xiaoxing Li | |||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 977-985 | |
| P577 | publication date | 2011-09-13 | |
| P1433 | published in | Gut | Q5621669 |
| P1476 | title | Epigenetic inactivation of BCL6B, a novel functional tumour suppressor for gastric cancer, is associated with poor survival | |
| P478 | volume | 61 |
| Q38738402 | A global burden of gastric cancer: the major impact of China. |
| Q34130236 | Aberrant DNA methyltransferase 1 expression in clear cell renal cell carcinoma development and progression |
| Q36299655 | BCL6B expression in hepatocellular carcinoma and its efficacy in the inhibition of liver damage and fibrogenesis |
| Q49379642 | BCL6B suppresses proliferation and migration of colorectal carcinoma cells through inhibition of the PI3K/AKT signaling pathway |
| Q64936827 | CAB39L elicited an anti-Warburg effect via a LKB1-AMPK-PGC1α axis to inhibit gastric tumorigenesis. |
| Q39286993 | Characterization of potential driver mutations involved in human breast cancer by computational approaches |
| Q34328551 | Clinicopathological significance and prognostic value of DNA methyltransferase 1, 3a, and 3b expressions in sporadic epithelial ovarian cancer |
| Q40704167 | Combinatorial epigenetic deregulation by Helicobacter pylori and Epstein-Barr virus infections in gastric tumourigenesis. |
| Q37697176 | Dapper homolog 1 alpha suppresses metastasis ability of gastric cancer through inhibiting planar cell polarity pathway |
| Q33564536 | Down-regulated expression of OPCML predicts an unfavorable prognosis and promotes disease progression in human gastric cancer |
| Q49663292 | Epigenetic biomarkers in gastrointestinal cancers: The current state and clinical perspectives |
| Q39321339 | Epigenetic modulation associated with carcinogenesis and prognosis of human gastric cancer. |
| Q44986560 | Epigenetic regulation of the novel tumor suppressor cysteine dioxygenase 1 in esophageal squamous cell carcinoma |
| Q35402307 | Epigenetic silencing BCL6B induced colorectal cancer proliferation and metastasis by inhibiting P53 signaling |
| Q42709400 | Epigenetic silencing of Aristaless-like homeobox-4, a potential tumor suppressor gene associated with lung cancer |
| Q35793851 | Epigenetic silencing of BCL6B inactivates p53 signaling and causes human hepatocellular carcinoma cell resist to 5-FU. |
| Q38115621 | Epigenetic-mediated tumor suppressor genes as diagnostic or prognostic biomarkers in gastric cancer |
| Q33718259 | Epigenetics: an emerging player in gastric cancer |
| Q36193792 | Evaluation of a novel functional single-nucleotide polymorphism (rs35010275 G>C) in MIR196A2 promoter region as a risk factor of gastric cancer in a Chinese population |
| Q34733206 | Expression profiling and clinicopathological significance of DNA methyltransferase 1, 3A and 3B in sporadic human renal cell carcinoma. |
| Q92713830 | FGF14 Functions as a Tumor Suppressor through Inhibiting PI3K/AKT/mTOR Pathway in Colorectal Cancer |
| Q99558657 | From Anti-EBV Immune Responses to the EBV Diseasome via Cross-reactivity |
| Q90340952 | Germline microsatellite genotypes differentiate children with medulloblastoma |
| Q96351260 | Global analysis of histone modifications and long-range chromatin interactions revealed the differential cistrome changes and novel transcriptional players in human dilated cardiomyopathy |
| Q41959589 | Immunohistochemical biomarkers in gastric cancer research and management |
| Q57453051 | Increased expression of heat shock factor 1 (HSF1) is associated with poor survival in gastric cancer patients |
| Q91750775 | Inhibition of Bcl6b promotes gastric cancer by amplifying inflammation in mice |
| Q57031381 | Integrated analysis of DNA methylation profiling and gene expression profiling identifies novel markers in lung cancer in Xuanwei, China |
| Q37663367 | KCNMA1 cooperating with PTK2 is a novel tumor suppressor in gastric cancer and is associated with disease outcome |
| Q37299656 | LHX6 acts as a novel potential tumour suppressor with epigenetic inactivation in lung cancer |
| Q23909987 | Long-term effects of carbon containing engineered nanomaterials and asbestos in the lung: one year postexposure comparisons |
| Q37282643 | MDGA2 is a novel tumour suppressor cooperating with DMAP1 in gastric cancer and is associated with disease outcome. |
| Q38134870 | Molecular pathogenesis of gastric cancer. |
| Q36350011 | Multiple region whole-exome sequencing reveals dramatically evolving intratumor genomic heterogeneity in esophageal squamous cell carcinoma |
| Q38556435 | Novel biomarkers for the identification and targeted therapy of gastric cancer |
| Q27012898 | Perspectives on new biomarkers in gastric cancer: diagnostic and prognostic applications |
| Q46860787 | Promoter hypermethylation of BCL6B gene is a potential plasma DNA biomarker for gastric cancer. |
| Q37590737 | REC8 functions as a tumor suppressor and is epigenetically downregulated in gastric cancer, especially in EBV-positive subtype |
| Q38843258 | Ras association domain family member 10 suppresses gastric cancer growth by cooperating with GSTP1 to regulate JNK/c-Jun/AP-1 pathway |
| Q36356293 | TMEM196 acts as a novel functional tumour suppressor inactivated by DNA methylation and is a potential prognostic biomarker in lung cancer |
| Q35127831 | Targeting of YAP1 by microRNA-15a and microRNA-16-1 exerts tumor suppressor function in gastric adenocarcinoma. |
| Q33987601 | The survival decrease in gastric cancer is associated with the methylation of B-cell CLL/lymphoma 6 member B promoter |
Search more.